AKT1 and inflammatory bowel disease: Enhanced AKT phosphorylation was evident in colonic biopsy of IBD patients and animal models of colitis, and treatment with wortmannin and AS605240 (PI3K inhibitors) ameliorated colitis severity [98, 99].